We are internationally known for our treatment outcomes and research in cystic fibrosis (CF) and primary ciliarydyskinesia (PCD). We are the only center in Denmark and among the leaders in Northern Europe in the field of interstitial lung diseases in children (chILD). Patients with complex lung diseases are often referred from all over the country for a "second opinion". The Pediatric Respiratory Physiology Laboratory exists as a fully integrated part of DBLC. The laboratory is specialised in refined and advanced methods of measuring different aspects of physiology and lung disease at various levels in the lung. DBLC also contributes to the training of pediatricians in the field of pediatric pulmonology.
Our research goals
We constantly strive to improve treatment results in our patients. This includes preventing and reducing the development of chronic lung damage, thereby increasing quality of life and survival. These goals are pursued through efforts in 3 key areas.
- A persistant search for basic knowledge about the various diseases, through clinical and basic science studies, in international collaborations.
- Searching for new opportunities in individualised treatment strategies using translational and clinical research.
- Close monitoring of treatment results and possible side effect, through retrospective database analysis.
Our location in Rigshospitalet facilitates a multidisciplinary approach to and collaboration about a variety of lung diseases including Asthma, Interstitial and diffuse lung diseases, Cystic Fibrosis, Primary Ciliary Dyskinesia, congenital lung malformations, as well as secondary diseases caused by damage to the peripheral airways following treatment of primary diseases such as childhood leukeamia.
Clinical & translationel research
Doctors and researchers at DBLC have contributed to important clinical and translational research. Here are some examples:
- Multiple Breath Gas Wash Out in children with chronic lung diseases and in healthy children.
- Structural lung changes in children with chronic lung diseases
- Nasal nitric oxide and pulmonary radioaerosol mucociliary clearance as supplementary tools in diagnosis of primary ciliary dyskinesia
June Kehlet Marthin
- Oxygen uptake and pulmonary diffusion capacity during rest and exercise breathing room air or 15 % oxygen.
- Exhaled nitric oxide in asthmatic children and diffuse interstitial lung disease
- Cystic fibrosis and Aspergillosis in CF
- Early diagnosis and treatment of lung infections in Cystic Fibrosis.
- Lung function and bronchial responsiveness in young children.
Kim Gjerum Nielsen
For further information please use the contact details below:
Rigshospitalet, BørneUngeKlinikken Opgang 5 Afsnit 5003
Blegdamsvej 9, 2100 København Ø
Tel: +45 35455006 or +45 35454802
Fax: +45 35456717